Abstract:ABSTRACT Metabolic syndrome (MetS) represents a cluster of major risk factors known to be associated with the development of aging-related diseases, such as cardiovascular disease and diabetes. Telomere length (TL) is often used as a cellular marker for biological age. Shorter TL indicates increased biological age. It is unknown whether maintenance of a short TL could be predictive for onset of metabolic diseases associated with increasing biological age. A number of studies found significant associations between shorter TL and dysregulated MetS components, but other studies did not confirm this finding. This cohort study investigated the relationship between shorter baseline TL and a worse metabolic profile with less favorable trajectories of MetS components over a 6-year follow-up. Participants included 2842 men and women aged 18 to 65 years who were part of The Netherlands Study of Depression and Anxiety, an ongoing prospective cohort study with 6-year follow-up. Telomere length from leukocytes was determined using quantitative polymerase chain reaction. Metabolic syndrome components (waist circumference, triglycerides, high-density lipoprotein &lsqb;HDL&rsqb;, cholesterol, fasting glucose, and systolic and diastolic blood pressure) were determined at baseline and after 2 and 6 years. Adjustments were made at baseline and 2- and 6-year follow-up for covariates (sociodemographic, lifestyle, and health factors) that could affect cross-sectional and longitudinal analyses. Shorter TL was cross-sectionally associated with a higher number of MetS abnormalities (&bgr; = 0.075, SE = 0.023, P = 0.001), higher waist circumference (&bgr; = 0.647, SE = 0.238, P = 0.007), triglycerides (&bgr; = .038, SE = 0.009, P < 0.001), and fasting glucose (&bgr; = 0.011, SE = 0.003, P < 0.001), and with lower HDL cholesterol (&bgr; = − 0.016, SE = 0.008, P = 0.05). No consistent patterns of association between TL and hypertension were found. Baseline differences progressively diminished over time; however, shorter baseline TL was still significantly associated with a worse level for most MetS components at both the 2- or 6-year follow-up. These findings show that cellular aging, as assessed by TL, is associated with a higher number of MetS abnormalities (representing a more severe metabolic risk profile) that persists even after a period of 6 years. The data suggest that a shorter TL could be predictive for the onset of various aging-related somatic diseases through its effect on metabolic alterations.

Telomere Length Variations in Aging and Age-Related Diseases

Telomeres and Telomere Length: A General Overview

Telomere Length as a marker of biological aging: A critical review of recent literature.

Telomere Shortening in Aging,Coronary Heart Disease and Cerebrovascular Diseases

The association of metabolic syndrome with telomere length as a marker of cellular aging: a systematic review and meta-analysis

Effects of Age and Biological Age-Determining Factors on Telomere Length in Type 2 Diabetes Mellitus Patients

Unravelling the role of telomere shortening with ageing and their potential association with diabetes, cancer, and related lifestyle factors

Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives

Involvement of Inheritance in Determining Telomere Length beyond Environmental and Lifestyle Factors

Telomere Length as a Marker of Cellular Aging Is Associated With Prevalence and Progression of Metabolic Syndrome

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection

Telomere length measurement as a clinical biomarker of aging and disease

Telomere length as a predictive biomarker in osteoporosis (Review)

The Importance of Telomere Shortening for Atherosclerosis and Mortality

Changes of telomere status with aging: An update

Telomeres and Mitochondrial Metabolism: Implications for Cellular Senescence and Age-related Diseases

Telomere Biology and Human Phenotype

Telomere length and aging-related outcomes in humans: A Mendelian randomization study in 261,000 older participants

Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease

Telomere Length Is a Driving Hallmark for Aging-Related Biochemical Hallmarks: Evidence From the Shared Genetic Effect and Causal Inference